Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®
Elaine S. DeMeyer, MSN, RN, AOCN®, BMTCN®, is the owner of beyond Oncology Education, LLC and has been a nurse entrepreneur for more than two decades. Elaine leverages her healthcare background along with creativity, business knowledge, and collaborative relationships.
Her mission through beyond Oncology is: To improve patient care by empowering oncology professionals with the tools and resources to change practice.
Articles by Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®
Learn what oncology nurses should know about how it works, the FDA-approved products, legal considerations, and more.
Oncology nurses must be prepared to use non-stigmatizing, culturally sensitive communication about cannabis to manage GVHD.
Oncology nurses need to monitor these 2 distinct but interconnected complications after allogeneic stem cell transplantation.
Learn how machine learning models may be able to assist interdisciplinary teams with tailoring GVHD management.
Oncology nurses need to be equipped to dispel common myths about smoking.
Learn how oncology nurses can offer education and smoking cessation resources to help patients reduce their risk.
Recent research highlights the need for proactive interventions by oncology nurses.
If patients who smoke understand the pathophysiology, they may be more open to difficult conversations about cessation.
This list of frequently asked questions can help you aid your patients in navigating insurance complexities.
Learn how oncology nurses can assess for CRS and ICANS, which are the main side effects of CAR-T and BiTE therapies.
Oncology nurses must understand how these therapies are similar but different regarding therapy-specific side effects.
Oncology nurses need to understand this complication to identify patients at high risk for steroid-induced hyperglycemia.
This common complication occurs in up to two-thirds of patients receiving steroids.
Oncology nurses have a central role in glycemia control, beginning with a clear assessment of glucose blood levels.
The Rios study revealed significant racial disparities in acute GVHD outcomes.
Learn how oncology nurses can help address disparities and bridge gaps to improve GVHD outcomes.
Oncology nurses may be the first to identify the classic triad of hyperviscosity syndrome symptoms.
Almost all patients with multiple myeloma at some point will develop bone disease—the “B” in CRAB.
Oncology nurses are integral to the success of ECP, as they provide ongoing education and psychosocial support to patients.
Before axatilimab, targeting the CSF-1R pathway was not previously studied in cGVHD.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.